Country-Specific Screening, Prevalence, and Immunity Rates for Hepatitis B Infection in a Large US Safety-Net System.

Authors:
Zhou K; Sumethasorn M; Wong C; Terrault NA.

Journal:
Open Forum Infect Dis

Publication Year: 2024

DOI:
10.1093/ofid/ofad699

PMCID:
PMC10810062

PMID:
38274550

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Open Forum Infect Dis

Abbreviation: Open Forum Infect Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Infectious Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A Baker's Dozen of Top Antimicrobial Stewardship Intervention Publications in 2022.
Barfield RK; Brown ML; Albrecht B and 27 more (2024) - Transparency Score: 3/6
Addressing Unmet PrEP Needs in Women: Impact of a Laboratory-Driven Protocol at an Urban, Essential…
Stewart J; Ruiz-Mercado G; Sperring H and 3 more (2024) - Transparency Score: 3/6
Adjunct Terbinafine in Patients With Leukemia and Invasive Fusariosis With Skin Lesions: Discordanc…
Matsuo T; Wurster S; Jiang Y and 2 more (2024) - Transparency Score: 3/6
Barriers to Hepatitis C Treatment and Interest in Telemedicine-Based Care Among Clients of a Syring…
Loy DE; Kamis K; Kanatser R and 1 more (2024) - Transparency Score: 2/6
Clinical Relevance of Human Immunodeficiency Virus Low-level Viremia in the Dolutegravir era: Data …
Kohler M; Brown JA; Tschumi N and 5 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Potential conflicts of interest. K. Z. reports institutional grant support from Gilead Sciences. N. A. T. discloses institutional grant support from Gilead Sciences, GSK, Helio Health, Eiger Pharmaceuticals, and Durect. All other authors report no potential conflicts Potential conflicts of interest ."

Evidence found in paper:

"Potential conflicts of interest. K. Z. reports institutional grant support from Gilead Sciences. N. A. T. discloses institutional grant support from Gilead Sciences, GSK, Helio Health, Eiger Pharmaceuticals, and Durect. All other authors report no potential conflicts"

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025